Schroder Adveq cPl Global Management III L.P. 3
3 · Decibel Therapeutics, Inc. · Filed Mar 8, 2021
Insider Transaction Report
Form 3
Schroder Adveq Technology IX S.C.S.
10% Owner
Holdings
- (indirect: See footnote)
Series C Preferred Stock
→ Common Stock (524,328 underlying) - (indirect: See footnote)
Series C Preferred Stock
→ Common Stock (524,328 underlying)
Footnotes (3)
- [F1]Each share of Series C Preferred Stock is convertible into shares of the Issuer???s common stock, $0.001 per value per share, on a 12.635:1 basis at any time at the holder???s election and will automatically convert immediately prior to the closing of the Issuer's initial public offering. The Series C Preferred Stock has no expiration date.
- [F2]Held directly by Schroder Adveq Technology IX S.C.S. Schroder Adveq Management Luxembourg S.a.r.l. is the general partner of Schroder Adveq Technology IX S.C.S. Schroder Adveq Management Luxembourg S.a.r.l. disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.
- [F3]Held directly by Schroder Adveq cPl Global 2017 - 2019 C.V. Schroder Adveq cPl Global Management III L.P. is the general partner of Schroder Adveq cPl Global 2017 - 2019 C.V. Schroder Adveq cPl Global Management III L.P. disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.